You can find the annual or quarterly income statement of HCW Biologics Inc here for insights into the performance and operational efficiency of HCW Biologics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

Total revenue

-96.34%15.61K

-98.94%6.55K

-99.55%5.07K

-70.18%394.80K

-50.02%426.42K

-0.63%618.85K

2590.14%1.13M

-1.31%1.32M

-52.84%853.10K

37.18%622.81K

-98.66%41.88K

--1.34M

--1.81M

--454.00K

--3.12M

-100.00%0.00

----

--4.10M

----

Revenue

-96.34%15.61K

-98.94%6.55K

-99.55%5.07K

-70.18%394.80K

-50.02%426.42K

-0.63%618.85K

2590.14%1.13M

-1.31%1.32M

-52.84%853.10K

37.18%622.81K

-98.66%41.88K

--1.34M

--1.81M

--454.00K

--3.12M

-100.00%0.00

----

--4.10M

----

Cost of revenue

-96.34%12.48K

-98.80%5.24K

-99.21%4.05K

-70.52%315.84K

-49.71%341.14K

-12.73%438.44K

1644.34%511.96K

-0.17%1.07M

-53.13%678.33K

74.93%502.40K

-97.79%29.35K

--1.07M

--1.45M

--287.20K

--1.33M

----

Operating expenses

-20.03%3.29M

-78.62%3.37M

-80.30%1.70M

-74.97%3.03M

-30.59%4.12M

206.91%15.75M

59.56%8.62M

72.53%12.09M

1.76%5.93M

29.46%5.13M

8.08%5.40M

125.18%7.01M

42.44%5.83M

44.13%3.97M

46.49%5.00M

52.68%3.11M

51.08%4.09M

-1.04%2.75M

42.35%3.41M

--2.04M

--2.71M

--2.78M

--2.40M

R&D expenses

18.58%1.38M

-40.13%1.20M

-30.88%1.45M

-52.09%1.02M

-30.37%1.16M

23.91%2.00M

-6.86%2.10M

-27.09%2.14M

-37.05%1.67M

-17.93%1.62M

26.05%2.26M

97.53%2.93M

-1.43%2.65M

17.73%1.97M

-23.18%1.79M

5.25%1.48M

28.05%2.69M

-19.12%1.67M

38.81%2.33M

--1.41M

--2.10M

--2.07M

--1.68M

Depreciation, depletion, and amortization

35.39%173.91K

124.67%291.92K

72.08%419.01K

148.59%682.51K

-53.70%128.45K

-54.30%129.93K

-18.52%243.50K

5.13%274.55K

68.84%277.45K

90.09%284.33K

109.30%298.85K

173.22%261.16K

32.40%164.33K

-9.40%149.58K

-10.09%142.78K

-41.60%95.58K

-1.66%124.12K

4.42%165.09K

7.37%158.81K

--163.69K

--126.21K

--158.11K

--147.90K

Other operating expenses

---12.48K

----

---1.74M

---2.91M

----

Operating profit

11.21%-3.28M

77.79%-3.36M

77.41%-1.69M

75.55%-2.63M

27.33%-3.69M

-235.57%-15.14M

-39.79%-7.49M

-90.01%-10.77M

-26.33%-5.08M

-28.47%-4.51M

-185.01%-5.36M

-82.08%-5.67M

1.77%-4.02M

-27.63%-3.51M

44.88%-1.88M

-251.01%-3.11M

-51.08%-4.09M

1.04%-2.75M

-42.35%-3.41M

--2.06M

---2.71M

---2.78M

---2.40M

Net non-operating interest income (expenses)

Non-operating interest income

----

--631.00

--865.00

----

Non-operating interest expense

-43.11%127.07K

43.25%228.71K

--255.82K

--248.11K

133.85%223.36K

67.17%159.67K

-100.00%0.00

----

--95.51K

--93.44K

----

Gains from sale of securities

---182.15K

----

Special income (expenses)

---981.79K

--1.65M

---273.06K

---527.30K

----

--0.00

----

--567.31K

----

Other non-operating income (expenses)

17.51%13.29K

5.73%16.37K

-3.33%24.75K

-59.89%34.59K

-95.18%11.31K

-94.87%15.48K

-93.32%25.60K

-71.70%86.24K

--234.75K

--301.62K

--383.32K

--304.74K

----

Income before tax

-16.71%-4.55M

87.38%-1.93M

70.58%-2.20M

68.42%-3.37M

20.98%-3.90M

-254.99%-15.28M

-47.28%-7.47M

-97.10%-10.68M

-26.17%-4.94M

-22.61%-4.30M

-146.48%-5.07M

-70.75%-5.42M

4.41%-3.91M

-27.64%-3.51M

27.66%-2.06M

-253.99%-3.17M

-51.15%-4.09M

1.01%-2.75M

-19.72%-2.84M

--2.06M

---2.71M

---2.78M

---2.38M

Income tax

----

--0.00

----

Income after tax

-16.71%-4.55M

87.38%-1.93M

70.58%-2.20M

68.42%-3.37M

20.98%-3.90M

-254.99%-15.28M

-47.28%-7.47M

-97.10%-10.68M

-26.17%-4.94M

-22.61%-4.30M

-146.48%-5.07M

-70.75%-5.42M

4.41%-3.91M

-27.64%-3.51M

27.66%-2.06M

-253.99%-3.17M

-51.15%-4.09M

1.01%-2.75M

-19.72%-2.84M

--2.06M

---2.71M

---2.78M

---2.38M

Net income from continuous operations

-16.71%-4.55M

87.38%-1.93M

70.58%-2.20M

68.42%-3.37M

20.98%-3.90M

-254.99%-15.28M

-47.28%-7.47M

-97.10%-10.68M

-26.17%-4.94M

-22.61%-4.30M

-146.48%-5.07M

-70.75%-5.42M

4.41%-3.91M

-27.64%-3.51M

27.66%-2.06M

-253.99%-3.17M

-51.15%-4.09M

1.01%-2.75M

-19.72%-2.84M

--2.06M

---2.71M

---2.78M

---2.38M

Net income attributable to controlling interests

-16.71%-4.55M

20.93%-12.08M

70.58%-2.20M

68.42%-3.37M

20.98%-3.90M

-254.99%-15.28M

-47.28%-7.47M

-97.10%-10.68M

-26.17%-4.94M

-22.61%-4.30M

-146.48%-5.07M

-70.75%-5.42M

4.41%-3.91M

-8.58%-3.51M

38.06%-2.06M

-294.50%-3.17M

-36.86%-4.09M

-5.71%-3.23M

-25.08%-3.32M

--1.63M

---2.99M

---3.06M

---2.66M

Preferred share dividend

----

-100.00%0.00

----

-100.00%0.00

72.51%482.66K

70.62%477.36K

--429.24K

--282.86K

--279.79K

Net income attributable to common shareholders

-16.71%-4.55M

20.93%-12.08M

70.58%-2.20M

68.42%-3.37M

20.98%-3.90M

-254.99%-15.28M

-47.28%-7.47M

-97.10%-10.68M

-26.17%-4.94M

-22.61%-4.30M

-146.48%-5.07M

-70.75%-5.42M

4.41%-3.91M

-8.58%-3.51M

38.06%-2.06M

-294.50%-3.17M

-36.86%-4.09M

-5.71%-3.23M

-25.08%-3.32M

--1.63M

---2.99M

---3.06M

---2.66M

Basic earnings per share

51.17%-2.02

58.00%-6.79

75.49%-1.97

73.13%-3.19

24.95%-4.13

-237.05%-16.16

-41.98%-8.03

-96.37%-11.87

-25.84%-5.50

-22.28%-4.79

-145.76%-5.65

-70.37%-6.04

4.69%-4.37

-8.31%-3.92

38.28%-2.30

-293.77%-3.55

-36.57%-4.58

-5.71%-3.62

-25.08%-3.73

--1.83

---3.36

---3.42

---2.98

Diluted earnings per share

51.17%-2.02

58.00%-6.79

75.49%-1.97

73.13%-3.19

24.95%-4.13

-237.05%-16.16

-41.98%-8.03

-96.37%-11.87

-25.84%-5.50

-22.28%-4.79

-145.76%-5.65

-70.37%-6.04

4.69%-4.37

-8.31%-3.92

38.28%-2.30

-293.77%-3.55

-36.57%-4.58

-5.71%-3.62

-25.08%-3.73

--1.83

---3.36

---3.42

---2.98

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

